Association of plasma xanthine oxidoreductase activity with severity and clinical outcome in patients with chronic heart failure

We provide the first evidence of an association of plasma XOR activity with CHF severity and clinical outcome. Plasma XOR activity could be used to identify high-risk CHF patients and could be a therapeutic target for XOR inhibitors.